nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—ABCC2—Paclitaxel—ovarian cancer	0.103	0.312	CbGbCtD
Furosemide—ABCC2—Carboplatin—ovarian cancer	0.0968	0.294	CbGbCtD
Furosemide—ABCC2—Docetaxel—ovarian cancer	0.0744	0.226	CbGbCtD
Furosemide—ABCC2—Doxorubicin—ovarian cancer	0.0554	0.168	CbGbCtD
Furosemide—CA5A—female reproductive system—ovarian cancer	0.00696	0.0422	CbGeAlD
Furosemide—SLCO2A1—myometrium—ovarian cancer	0.00548	0.0332	CbGeAlD
Furosemide—PGD—myometrium—ovarian cancer	0.00489	0.0296	CbGeAlD
Furosemide—SLC12A1—epithelium—ovarian cancer	0.00466	0.0283	CbGeAlD
Furosemide—SLCO2A1—epithelium—ovarian cancer	0.0043	0.0261	CbGeAlD
Furosemide—SLCO2A1—uterine cervix—ovarian cancer	0.00427	0.0259	CbGeAlD
Furosemide—CA9—female reproductive system—ovarian cancer	0.00407	0.0247	CbGeAlD
Furosemide—SLCO2A1—decidua—ovarian cancer	0.00406	0.0246	CbGeAlD
Furosemide—SLCO2A1—endometrium—ovarian cancer	0.00386	0.0234	CbGeAlD
Furosemide—PGD—uterine cervix—ovarian cancer	0.0038	0.0231	CbGeAlD
Furosemide—PGD—decidua—ovarian cancer	0.00362	0.022	CbGeAlD
Furosemide—SLC22A11—female reproductive system—ovarian cancer	0.00356	0.0216	CbGeAlD
Furosemide—SLCO2A1—uterus—ovarian cancer	0.00356	0.0216	CbGeAlD
Furosemide—PGD—endometrium—ovarian cancer	0.00344	0.0208	CbGeAlD
Furosemide—CA9—testis—ovarian cancer	0.00328	0.0199	CbGeAlD
Furosemide—SLCO2A1—female reproductive system—ovarian cancer	0.0032	0.0194	CbGeAlD
Furosemide—PGD—gonad—ovarian cancer	0.00319	0.0193	CbGeAlD
Furosemide—PGD—uterus—ovarian cancer	0.00317	0.0192	CbGeAlD
Furosemide—CA5B—gonad—ovarian cancer	0.00302	0.0183	CbGeAlD
Furosemide—CA12—female reproductive system—ovarian cancer	0.00301	0.0182	CbGeAlD
Furosemide—SLCO2A1—female gonad—ovarian cancer	0.00291	0.0176	CbGeAlD
Furosemide—SLCO2A1—vagina—ovarian cancer	0.00289	0.0175	CbGeAlD
Furosemide—PGD—female reproductive system—ovarian cancer	0.00285	0.0173	CbGeAlD
Furosemide—SLC12A1—testis—ovarian cancer	0.00279	0.0169	CbGeAlD
Furosemide—CA5B—female reproductive system—ovarian cancer	0.0027	0.0164	CbGeAlD
Furosemide—PGD—bone marrow—ovarian cancer	0.00269	0.0163	CbGeAlD
Furosemide—SLC22A5—myometrium—ovarian cancer	0.00261	0.0158	CbGeAlD
Furosemide—PGD—female gonad—ovarian cancer	0.00259	0.0157	CbGeAlD
Furosemide—SLCO2A1—testis—ovarian cancer	0.00258	0.0156	CbGeAlD
Furosemide—PGD—vagina—ovarian cancer	0.00258	0.0156	CbGeAlD
Furosemide—CA2—embryo—ovarian cancer	0.00255	0.0154	CbGeAlD
Furosemide—CA5B—vagina—ovarian cancer	0.00244	0.0148	CbGeAlD
Furosemide—CA1—female reproductive system—ovarian cancer	0.00238	0.0144	CbGeAlD
Furosemide—PGD—testis—ovarian cancer	0.0023	0.0139	CbGeAlD
Furosemide—CA1—bone marrow—ovarian cancer	0.00225	0.0136	CbGeAlD
Furosemide—CA5B—testis—ovarian cancer	0.00218	0.0132	CbGeAlD
Furosemide—CA2—epithelium—ovarian cancer	0.00208	0.0126	CbGeAlD
Furosemide—SLC22A5—uterine cervix—ovarian cancer	0.00203	0.0123	CbGeAlD
Furosemide—CA2—decidua—ovarian cancer	0.00196	0.0119	CbGeAlD
Furosemide—ABCC2—female reproductive system—ovarian cancer	0.00196	0.0119	CbGeAlD
Furosemide—SLCO2A1—lymph node—ovarian cancer	0.00187	0.0113	CbGeAlD
Furosemide—CA4—female reproductive system—ovarian cancer	0.00186	0.0113	CbGeAlD
Furosemide—SLC22A5—endometrium—ovarian cancer	0.00183	0.0111	CbGeAlD
Furosemide—CA4—bone marrow—ovarian cancer	0.00176	0.0107	CbGeAlD
Furosemide—CA4—female gonad—ovarian cancer	0.00169	0.0103	CbGeAlD
Furosemide—ALB—testis—ovarian cancer	0.00169	0.0102	CbGeAlD
Furosemide—PGD—lymph node—ovarian cancer	0.00167	0.0101	CbGeAlD
Furosemide—ABCC2—testis—ovarian cancer	0.00158	0.0096	CbGeAlD
Furosemide—CA5B—lymph node—ovarian cancer	0.00158	0.00957	CbGeAlD
Furosemide—CA2—female reproductive system—ovarian cancer	0.00154	0.00936	CbGeAlD
Furosemide—SLC22A5—female reproductive system—ovarian cancer	0.00152	0.00921	CbGeAlD
Furosemide—CA4—testis—ovarian cancer	0.0015	0.00911	CbGeAlD
Furosemide—CA2—bone marrow—ovarian cancer	0.00146	0.00884	CbGeAlD
Furosemide—CA2—female gonad—ovarian cancer	0.00141	0.00852	CbGeAlD
Furosemide—CA2—vagina—ovarian cancer	0.0014	0.00847	CbGeAlD
Furosemide—CA1—lymph node—ovarian cancer	0.00139	0.00845	CbGeAlD
Furosemide—SLC22A5—female gonad—ovarian cancer	0.00138	0.00838	CbGeAlD
Furosemide—SLC22A5—vagina—ovarian cancer	0.00137	0.00833	CbGeAlD
Furosemide—CA2—testis—ovarian cancer	0.00125	0.00756	CbGeAlD
Furosemide—SLC22A5—testis—ovarian cancer	0.00123	0.00743	CbGeAlD
Furosemide—ALB—lymph node—ovarian cancer	0.00122	0.00742	CbGeAlD
Furosemide—ABCC2—lymph node—ovarian cancer	0.00115	0.00696	CbGeAlD
Furosemide—CA4—lymph node—ovarian cancer	0.00109	0.00661	CbGeAlD
Furosemide—CA2—lymph node—ovarian cancer	0.000903	0.00548	CbGeAlD
Furosemide—SLC22A5—lymph node—ovarian cancer	0.000889	0.00539	CbGeAlD
Furosemide—Hyponatraemia—Epirubicin—ovarian cancer	0.000627	0.00126	CcSEcCtD
Furosemide—Diarrhoea—Melphalan—ovarian cancer	0.000625	0.00125	CcSEcCtD
Furosemide—Nausea—Chlorambucil—ovarian cancer	0.000622	0.00125	CcSEcCtD
Furosemide—Vision blurred—Paclitaxel—ovarian cancer	0.00062	0.00124	CcSEcCtD
Furosemide—Visual impairment—Docetaxel—ovarian cancer	0.000617	0.00124	CcSEcCtD
Furosemide—Dizziness—Topotecan—ovarian cancer	0.000617	0.00124	CcSEcCtD
Furosemide—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000612	0.00123	CcSEcCtD
Furosemide—Anaemia—Paclitaxel—ovarian cancer	0.000608	0.00122	CcSEcCtD
Furosemide—Erythema multiforme—Docetaxel—ovarian cancer	0.000605	0.00122	CcSEcCtD
Furosemide—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000604	0.00121	CcSEcCtD
Furosemide—Agitation—Paclitaxel—ovarian cancer	0.000604	0.00121	CcSEcCtD
Furosemide—Purpura—Doxorubicin—ovarian cancer	0.000599	0.0012	CcSEcCtD
Furosemide—Eye disorder—Docetaxel—ovarian cancer	0.000598	0.0012	CcSEcCtD
Furosemide—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000597	0.0012	CcSEcCtD
Furosemide—Vomiting—Topotecan—ovarian cancer	0.000593	0.00119	CcSEcCtD
Furosemide—Vertigo—Paclitaxel—ovarian cancer	0.000591	0.00119	CcSEcCtD
Furosemide—Lethargy—Doxorubicin—ovarian cancer	0.000589	0.00118	CcSEcCtD
Furosemide—Leukopenia—Paclitaxel—ovarian cancer	0.000589	0.00118	CcSEcCtD
Furosemide—Rash—Topotecan—ovarian cancer	0.000588	0.00118	CcSEcCtD
Furosemide—Hypersensitivity—Vinorelbine—ovarian cancer	0.000588	0.00118	CcSEcCtD
Furosemide—Dermatitis—Topotecan—ovarian cancer	0.000587	0.00118	CcSEcCtD
Furosemide—Blood creatinine increased—Epirubicin—ovarian cancer	0.000585	0.00117	CcSEcCtD
Furosemide—Headache—Topotecan—ovarian cancer	0.000584	0.00117	CcSEcCtD
Furosemide—Angiopathy—Docetaxel—ovarian cancer	0.000581	0.00117	CcSEcCtD
Furosemide—Vomiting—Melphalan—ovarian cancer	0.000581	0.00117	CcSEcCtD
Furosemide—Dehydration—Epirubicin—ovarian cancer	0.00058	0.00117	CcSEcCtD
Furosemide—Hyponatraemia—Doxorubicin—ovarian cancer	0.00058	0.00116	CcSEcCtD
Furosemide—Immune system disorder—Docetaxel—ovarian cancer	0.000578	0.00116	CcSEcCtD
Furosemide—Rash—Melphalan—ovarian cancer	0.000576	0.00116	CcSEcCtD
Furosemide—Dermatitis—Melphalan—ovarian cancer	0.000575	0.00116	CcSEcCtD
Furosemide—Asthenia—Vinorelbine—ovarian cancer	0.000572	0.00115	CcSEcCtD
Furosemide—Arrhythmia—Docetaxel—ovarian cancer	0.000572	0.00115	CcSEcCtD
Furosemide—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00057	0.00114	CcSEcCtD
Furosemide—Hypokalaemia—Epirubicin—ovarian cancer	0.000568	0.00114	CcSEcCtD
Furosemide—Pruritus—Vinorelbine—ovarian cancer	0.000564	0.00113	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000562	0.00113	CcSEcCtD
Furosemide—Erythema—Docetaxel—ovarian cancer	0.000557	0.00112	CcSEcCtD
Furosemide—Malnutrition—Docetaxel—ovarian cancer	0.000557	0.00112	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000556	0.00112	CcSEcCtD
Furosemide—Nausea—Topotecan—ovarian cancer	0.000554	0.00111	CcSEcCtD
Furosemide—Muscular weakness—Epirubicin—ovarian cancer	0.000551	0.00111	CcSEcCtD
Furosemide—Dry mouth—Paclitaxel—ovarian cancer	0.000547	0.0011	CcSEcCtD
Furosemide—Diarrhoea—Vinorelbine—ovarian cancer	0.000546	0.0011	CcSEcCtD
Furosemide—Dysgeusia—Docetaxel—ovarian cancer	0.000546	0.0011	CcSEcCtD
Furosemide—Abdominal distension—Epirubicin—ovarian cancer	0.000543	0.00109	CcSEcCtD
Furosemide—Nausea—Melphalan—ovarian cancer	0.000542	0.00109	CcSEcCtD
Furosemide—Confusional state—Paclitaxel—ovarian cancer	0.000541	0.00109	CcSEcCtD
Furosemide—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000541	0.00109	CcSEcCtD
Furosemide—Dehydration—Doxorubicin—ovarian cancer	0.000537	0.00108	CcSEcCtD
Furosemide—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000537	0.00108	CcSEcCtD
Furosemide—Muscle spasms—Docetaxel—ovarian cancer	0.000536	0.00108	CcSEcCtD
Furosemide—Eosinophilia—Epirubicin—ovarian cancer	0.000534	0.00107	CcSEcCtD
Furosemide—Pancreatitis—Epirubicin—ovarian cancer	0.000529	0.00106	CcSEcCtD
Furosemide—Shock—Paclitaxel—ovarian cancer	0.000528	0.00106	CcSEcCtD
Furosemide—Dizziness—Vinorelbine—ovarian cancer	0.000528	0.00106	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000527	0.00106	CcSEcCtD
Furosemide—Nervous system disorder—Paclitaxel—ovarian cancer	0.000526	0.00106	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—ovarian cancer	0.000526	0.00106	CcSEcCtD
Furosemide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000525	0.00105	CcSEcCtD
Furosemide—Skin disorder—Paclitaxel—ovarian cancer	0.000521	0.00105	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00052	0.00104	CcSEcCtD
Furosemide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000519	0.00104	CcSEcCtD
Furosemide—Anaemia—Docetaxel—ovarian cancer	0.000515	0.00103	CcSEcCtD
Furosemide—Anorexia—Paclitaxel—ovarian cancer	0.000512	0.00103	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—ovarian cancer	0.000509	0.00102	CcSEcCtD
Furosemide—Vomiting—Vinorelbine—ovarian cancer	0.000507	0.00102	CcSEcCtD
Furosemide—Rash—Vinorelbine—ovarian cancer	0.000503	0.00101	CcSEcCtD
Furosemide—Dermatitis—Vinorelbine—ovarian cancer	0.000503	0.00101	CcSEcCtD
Furosemide—Abdominal distension—Doxorubicin—ovarian cancer	0.000503	0.00101	CcSEcCtD
Furosemide—Hypotension—Paclitaxel—ovarian cancer	0.000501	0.00101	CcSEcCtD
Furosemide—Headache—Vinorelbine—ovarian cancer	0.0005	0.001	CcSEcCtD
Furosemide—Leukopenia—Docetaxel—ovarian cancer	0.000499	0.001	CcSEcCtD
Furosemide—Pollakiuria—Epirubicin—ovarian cancer	0.000498	0.001	CcSEcCtD
Furosemide—Eosinophilia—Doxorubicin—ovarian cancer	0.000494	0.000992	CcSEcCtD
Furosemide—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000492	0.000989	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—ovarian cancer	0.000489	0.000983	CcSEcCtD
Furosemide—Hyperglycaemia—Epirubicin—ovarian cancer	0.000487	0.000977	CcSEcCtD
Furosemide—Paraesthesia—Paclitaxel—ovarian cancer	0.000482	0.000968	CcSEcCtD
Furosemide—Drowsiness—Epirubicin—ovarian cancer	0.000481	0.000966	CcSEcCtD
Furosemide—Somnolence—Paclitaxel—ovarian cancer	0.000477	0.000958	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000477	0.000958	CcSEcCtD
Furosemide—Nausea—Vinorelbine—ovarian cancer	0.000474	0.000952	CcSEcCtD
Furosemide—Renal failure—Epirubicin—ovarian cancer	0.000473	0.000949	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000471	0.000946	CcSEcCtD
Furosemide—Decreased appetite—Paclitaxel—ovarian cancer	0.000466	0.000937	CcSEcCtD
Furosemide—Dry mouth—Docetaxel—ovarian cancer	0.000464	0.000932	CcSEcCtD
Furosemide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000463	0.00093	CcSEcCtD
Furosemide—Fatigue—Paclitaxel—ovarian cancer	0.000463	0.000929	CcSEcCtD
Furosemide—Sweating—Epirubicin—ovarian cancer	0.000461	0.000926	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—ovarian cancer	0.000461	0.000926	CcSEcCtD
Furosemide—Constipation—Paclitaxel—ovarian cancer	0.000459	0.000921	CcSEcCtD
Furosemide—Pain—Paclitaxel—ovarian cancer	0.000459	0.000921	CcSEcCtD
Furosemide—Confusional state—Docetaxel—ovarian cancer	0.000459	0.000921	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000456	0.000915	CcSEcCtD
Furosemide—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000455	0.000913	CcSEcCtD
Furosemide—Anaphylactic shock—Docetaxel—ovarian cancer	0.000455	0.000913	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00045	0.000904	CcSEcCtD
Furosemide—Agranulocytosis—Epirubicin—ovarian cancer	0.000449	0.000901	CcSEcCtD
Furosemide—Shock—Docetaxel—ovarian cancer	0.000447	0.000899	CcSEcCtD
Furosemide—Nervous system disorder—Docetaxel—ovarian cancer	0.000446	0.000896	CcSEcCtD
Furosemide—Thrombocytopenia—Docetaxel—ovarian cancer	0.000445	0.000894	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—ovarian cancer	0.000445	0.000894	CcSEcCtD
Furosemide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000442	0.000888	CcSEcCtD
Furosemide—Skin disorder—Docetaxel—ovarian cancer	0.000442	0.000887	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000441	0.000886	CcSEcCtD
Furosemide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000439	0.000881	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—ovarian cancer	0.000438	0.000878	CcSEcCtD
Furosemide—Anorexia—Docetaxel—ovarian cancer	0.000434	0.000871	CcSEcCtD
Furosemide—Sweating—Doxorubicin—ovarian cancer	0.000427	0.000857	CcSEcCtD
Furosemide—Urinary tract disorder—Epirubicin—ovarian cancer	0.000426	0.000856	CcSEcCtD
Furosemide—Urticaria—Paclitaxel—ovarian cancer	0.000426	0.000856	CcSEcCtD
Furosemide—Hypotension—Docetaxel—ovarian cancer	0.000425	0.000853	CcSEcCtD
Furosemide—Abdominal pain—Paclitaxel—ovarian cancer	0.000424	0.000852	CcSEcCtD
Furosemide—Body temperature increased—Paclitaxel—ovarian cancer	0.000424	0.000852	CcSEcCtD
Furosemide—Urethral disorder—Epirubicin—ovarian cancer	0.000423	0.00085	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000421	0.000845	CcSEcCtD
Furosemide—Visual impairment—Epirubicin—ovarian cancer	0.000416	0.000836	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—ovarian cancer	0.000415	0.000834	CcSEcCtD
Furosemide—Paraesthesia—Docetaxel—ovarian cancer	0.000408	0.00082	CcSEcCtD
Furosemide—Erythema multiforme—Epirubicin—ovarian cancer	0.000408	0.00082	CcSEcCtD
Furosemide—Somnolence—Docetaxel—ovarian cancer	0.000404	0.000812	CcSEcCtD
Furosemide—Eye disorder—Epirubicin—ovarian cancer	0.000404	0.00081	CcSEcCtD
Furosemide—Tinnitus—Epirubicin—ovarian cancer	0.000403	0.000808	CcSEcCtD
Furosemide—Decreased appetite—Docetaxel—ovarian cancer	0.000395	0.000794	CcSEcCtD
Furosemide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000395	0.000794	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000395	0.000792	CcSEcCtD
Furosemide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000393	0.000788	CcSEcCtD
Furosemide—Fatigue—Docetaxel—ovarian cancer	0.000392	0.000787	CcSEcCtD
Furosemide—Angiopathy—Epirubicin—ovarian cancer	0.000392	0.000787	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—ovarian cancer	0.000392	0.000786	CcSEcCtD
Furosemide—Immune system disorder—Epirubicin—ovarian cancer	0.00039	0.000783	CcSEcCtD
Furosemide—Pain—Docetaxel—ovarian cancer	0.000389	0.000781	CcSEcCtD
Furosemide—Constipation—Docetaxel—ovarian cancer	0.000389	0.000781	CcSEcCtD
Furosemide—Arrhythmia—Epirubicin—ovarian cancer	0.000386	0.000775	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—ovarian cancer	0.000385	0.000773	CcSEcCtD
Furosemide—Asthenia—Paclitaxel—ovarian cancer	0.000385	0.000773	CcSEcCtD
Furosemide—Pruritus—Paclitaxel—ovarian cancer	0.00038	0.000762	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—ovarian cancer	0.000378	0.000759	CcSEcCtD
Furosemide—Erythema—Epirubicin—ovarian cancer	0.000376	0.000755	CcSEcCtD
Furosemide—Malnutrition—Epirubicin—ovarian cancer	0.000376	0.000755	CcSEcCtD
Furosemide—Feeling abnormal—Docetaxel—ovarian cancer	0.000375	0.000753	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—ovarian cancer	0.000373	0.00075	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—ovarian cancer	0.000373	0.000748	CcSEcCtD
Furosemide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000372	0.000747	CcSEcCtD
Furosemide—Flatulence—Epirubicin—ovarian cancer	0.00037	0.000744	CcSEcCtD
Furosemide—Dysgeusia—Epirubicin—ovarian cancer	0.000368	0.000739	CcSEcCtD
Furosemide—Diarrhoea—Paclitaxel—ovarian cancer	0.000367	0.000737	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—ovarian cancer	0.000362	0.000728	CcSEcCtD
Furosemide—Muscle spasms—Epirubicin—ovarian cancer	0.000361	0.000726	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—ovarian cancer	0.000361	0.000725	CcSEcCtD
Furosemide—Abdominal pain—Docetaxel—ovarian cancer	0.00036	0.000722	CcSEcCtD
Furosemide—Body temperature increased—Docetaxel—ovarian cancer	0.00036	0.000722	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—ovarian cancer	0.000357	0.000717	CcSEcCtD
Furosemide—Dizziness—Paclitaxel—ovarian cancer	0.000355	0.000713	CcSEcCtD
Furosemide—Vision blurred—Epirubicin—ovarian cancer	0.000354	0.000711	CcSEcCtD
Furosemide—Erythema—Doxorubicin—ovarian cancer	0.000348	0.000698	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—ovarian cancer	0.000348	0.000698	CcSEcCtD
Furosemide—Anaemia—Epirubicin—ovarian cancer	0.000347	0.000698	CcSEcCtD
Furosemide—Agitation—Epirubicin—ovarian cancer	0.000345	0.000694	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—ovarian cancer	0.000343	0.000688	CcSEcCtD
Furosemide—Vomiting—Paclitaxel—ovarian cancer	0.000341	0.000685	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—ovarian cancer	0.000341	0.000684	CcSEcCtD
Furosemide—Rash—Paclitaxel—ovarian cancer	0.000338	0.000679	CcSEcCtD
Furosemide—Dermatitis—Paclitaxel—ovarian cancer	0.000338	0.000679	CcSEcCtD
Furosemide—Vertigo—Epirubicin—ovarian cancer	0.000338	0.000678	CcSEcCtD
Furosemide—Leukopenia—Epirubicin—ovarian cancer	0.000336	0.000676	CcSEcCtD
Furosemide—Headache—Paclitaxel—ovarian cancer	0.000336	0.000675	CcSEcCtD
Furosemide—Hypersensitivity—Docetaxel—ovarian cancer	0.000335	0.000673	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—ovarian cancer	0.000334	0.000671	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—ovarian cancer	0.000328	0.000658	CcSEcCtD
Furosemide—Asthenia—Docetaxel—ovarian cancer	0.000326	0.000655	CcSEcCtD
Furosemide—Pruritus—Docetaxel—ovarian cancer	0.000322	0.000646	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—ovarian cancer	0.000321	0.000645	CcSEcCtD
Furosemide—Agitation—Doxorubicin—ovarian cancer	0.00032	0.000642	CcSEcCtD
Furosemide—Nausea—Paclitaxel—ovarian cancer	0.000319	0.00064	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000318	0.000638	CcSEcCtD
Furosemide—Dry mouth—Epirubicin—ovarian cancer	0.000313	0.000628	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—ovarian cancer	0.000312	0.000627	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—ovarian cancer	0.000311	0.000625	CcSEcCtD
Furosemide—Diarrhoea—Docetaxel—ovarian cancer	0.000311	0.000625	CcSEcCtD
Furosemide—Confusional state—Epirubicin—ovarian cancer	0.000309	0.000621	CcSEcCtD
Furosemide—Anaphylactic shock—Epirubicin—ovarian cancer	0.000307	0.000616	CcSEcCtD
Furosemide—Shock—Epirubicin—ovarian cancer	0.000302	0.000606	CcSEcCtD
Furosemide—Nervous system disorder—Epirubicin—ovarian cancer	0.000301	0.000604	CcSEcCtD
Furosemide—Dizziness—Docetaxel—ovarian cancer	0.000301	0.000604	CcSEcCtD
Furosemide—Thrombocytopenia—Epirubicin—ovarian cancer	0.0003	0.000603	CcSEcCtD
Furosemide—Skin disorder—Epirubicin—ovarian cancer	0.000298	0.000598	CcSEcCtD
Furosemide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000297	0.000596	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000294	0.00059	CcSEcCtD
Furosemide—Anorexia—Epirubicin—ovarian cancer	0.000292	0.000587	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—ovarian cancer	0.00029	0.000581	CcSEcCtD
Furosemide—Vomiting—Docetaxel—ovarian cancer	0.000289	0.000581	CcSEcCtD
Furosemide—Rash—Docetaxel—ovarian cancer	0.000287	0.000576	CcSEcCtD
Furosemide—Hypotension—Epirubicin—ovarian cancer	0.000287	0.000576	CcSEcCtD
Furosemide—Dermatitis—Docetaxel—ovarian cancer	0.000287	0.000575	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—ovarian cancer	0.000286	0.000575	CcSEcCtD
Furosemide—Headache—Docetaxel—ovarian cancer	0.000285	0.000572	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000284	0.00057	CcSEcCtD
Furosemide—Shock—Doxorubicin—ovarian cancer	0.000279	0.000561	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000278	0.000559	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000278	0.000558	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—ovarian cancer	0.000276	0.000554	CcSEcCtD
Furosemide—Paraesthesia—Epirubicin—ovarian cancer	0.000275	0.000553	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000274	0.000551	CcSEcCtD
Furosemide—Somnolence—Epirubicin—ovarian cancer	0.000273	0.000548	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—ovarian cancer	0.000271	0.000543	CcSEcCtD
Furosemide—Nausea—Docetaxel—ovarian cancer	0.00027	0.000542	CcSEcCtD
Furosemide—Decreased appetite—Epirubicin—ovarian cancer	0.000267	0.000535	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—ovarian cancer	0.000265	0.000533	CcSEcCtD
Furosemide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000265	0.000532	CcSEcCtD
Furosemide—Fatigue—Epirubicin—ovarian cancer	0.000264	0.000531	CcSEcCtD
Furosemide—Constipation—Epirubicin—ovarian cancer	0.000262	0.000527	CcSEcCtD
Furosemide—Pain—Epirubicin—ovarian cancer	0.000262	0.000527	CcSEcCtD
Furosemide—Paraesthesia—Doxorubicin—ovarian cancer	0.000255	0.000512	CcSEcCtD
Furosemide—Feeling abnormal—Epirubicin—ovarian cancer	0.000253	0.000508	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—ovarian cancer	0.000252	0.000507	CcSEcCtD
Furosemide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000251	0.000504	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—ovarian cancer	0.000247	0.000495	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000245	0.000492	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—ovarian cancer	0.000245	0.000491	CcSEcCtD
Furosemide—Urticaria—Epirubicin—ovarian cancer	0.000244	0.000489	CcSEcCtD
Furosemide—Constipation—Doxorubicin—ovarian cancer	0.000243	0.000487	CcSEcCtD
Furosemide—Pain—Doxorubicin—ovarian cancer	0.000243	0.000487	CcSEcCtD
Furosemide—Abdominal pain—Epirubicin—ovarian cancer	0.000243	0.000487	CcSEcCtD
Furosemide—Body temperature increased—Epirubicin—ovarian cancer	0.000243	0.000487	CcSEcCtD
Furosemide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000234	0.00047	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000232	0.000466	CcSEcCtD
Furosemide—Hypersensitivity—Epirubicin—ovarian cancer	0.000226	0.000454	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—ovarian cancer	0.000226	0.000453	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—ovarian cancer	0.000224	0.000451	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—ovarian cancer	0.000224	0.000451	CcSEcCtD
Furosemide—Asthenia—Epirubicin—ovarian cancer	0.00022	0.000442	CcSEcCtD
Furosemide—Pruritus—Epirubicin—ovarian cancer	0.000217	0.000436	CcSEcCtD
Furosemide—Diarrhoea—Epirubicin—ovarian cancer	0.00021	0.000421	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000209	0.00042	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—ovarian cancer	0.000204	0.000409	CcSEcCtD
Furosemide—Dizziness—Epirubicin—ovarian cancer	0.000203	0.000407	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—ovarian cancer	0.000201	0.000403	CcSEcCtD
Furosemide—Vomiting—Epirubicin—ovarian cancer	0.000195	0.000392	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—ovarian cancer	0.000194	0.00039	CcSEcCtD
Furosemide—Rash—Epirubicin—ovarian cancer	0.000193	0.000388	CcSEcCtD
Furosemide—Dermatitis—Epirubicin—ovarian cancer	0.000193	0.000388	CcSEcCtD
Furosemide—Headache—Epirubicin—ovarian cancer	0.000192	0.000386	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—ovarian cancer	0.000188	0.000377	CcSEcCtD
Furosemide—Nausea—Epirubicin—ovarian cancer	0.000182	0.000366	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—ovarian cancer	0.00018	0.000362	CcSEcCtD
Furosemide—Rash—Doxorubicin—ovarian cancer	0.000179	0.000359	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—ovarian cancer	0.000179	0.000359	CcSEcCtD
Furosemide—Headache—Doxorubicin—ovarian cancer	0.000178	0.000357	CcSEcCtD
Furosemide—Nausea—Doxorubicin—ovarian cancer	0.000169	0.000339	CcSEcCtD
Furosemide—CA7—Metabolism—SLC2A1—ovarian cancer	1.31e-05	0.00174	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SLC2A1—ovarian cancer	1.31e-05	0.00174	CbGpPWpGaD
Furosemide—PGD—Metabolism—CYP1B1—ovarian cancer	1.3e-05	0.00172	CbGpPWpGaD
Furosemide—CA12—Metabolism—FASN—ovarian cancer	1.28e-05	0.00169	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC5A5—ovarian cancer	1.25e-05	0.00166	CbGpPWpGaD
Furosemide—CA7—Metabolism—CYP1B1—ovarian cancer	1.25e-05	0.00166	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CYP1B1—ovarian cancer	1.25e-05	0.00166	CbGpPWpGaD
Furosemide—CA4—Metabolism—YAP1—ovarian cancer	1.25e-05	0.00166	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.24e-05	0.00165	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.24e-05	0.00165	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL2—ovarian cancer	1.23e-05	0.00163	CbGpPWpGaD
Furosemide—CA14—Metabolism—PPP2R1A—ovarian cancer	1.22e-05	0.00162	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC2A1—ovarian cancer	1.21e-05	0.00161	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.2e-05	0.00159	CbGpPWpGaD
Furosemide—CA2—Metabolism—YAP1—ovarian cancer	1.2e-05	0.00159	CbGpPWpGaD
Furosemide—CA6—Metabolism—PPP2R1A—ovarian cancer	1.19e-05	0.00158	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PPP2R1A—ovarian cancer	1.19e-05	0.00158	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP1B1—ovarian cancer	1.16e-05	0.00154	CbGpPWpGaD
Furosemide—PGD—Metabolism—PPP2R1A—ovarian cancer	1.15e-05	0.00153	CbGpPWpGaD
Furosemide—CA1—Metabolism—YAP1—ovarian cancer	1.15e-05	0.00152	CbGpPWpGaD
Furosemide—CA14—Metabolism—ABCB1—ovarian cancer	1.13e-05	0.00151	CbGpPWpGaD
Furosemide—CA14—Metabolism—TYMS—ovarian cancer	1.11e-05	0.00148	CbGpPWpGaD
Furosemide—CA7—Metabolism—PPP2R1A—ovarian cancer	1.11e-05	0.00148	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PPP2R1A—ovarian cancer	1.11e-05	0.00148	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ABCB1—ovarian cancer	1.11e-05	0.00147	CbGpPWpGaD
Furosemide—CA6—Metabolism—ABCB1—ovarian cancer	1.11e-05	0.00147	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—VEGFA—ovarian cancer	1.1e-05	0.00146	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—STAT3—ovarian cancer	1.09e-05	0.00145	CbGpPWpGaD
Furosemide—PGD—Disease—TERT—ovarian cancer	1.09e-05	0.00145	CbGpPWpGaD
Furosemide—CA6—Metabolism—TYMS—ovarian cancer	1.09e-05	0.00144	CbGpPWpGaD
Furosemide—CA5A—Metabolism—TYMS—ovarian cancer	1.09e-05	0.00144	CbGpPWpGaD
Furosemide—PGD—Metabolism—ABCB1—ovarian cancer	1.07e-05	0.00142	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	1.06e-05	0.00141	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	1.06e-05	0.00141	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.05e-05	0.0014	CbGpPWpGaD
Furosemide—PGD—Metabolism—TYMS—ovarian cancer	1.05e-05	0.00139	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.05e-05	0.00139	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—MAPK3—ovarian cancer	1.04e-05	0.00138	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.04e-05	0.00137	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ABCB1—ovarian cancer	1.03e-05	0.00137	CbGpPWpGaD
Furosemide—CA7—Metabolism—ABCB1—ovarian cancer	1.03e-05	0.00137	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPP2R1A—ovarian cancer	1.03e-05	0.00137	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	1.02e-05	0.00136	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	1.02e-05	0.00135	CbGpPWpGaD
Furosemide—CA4—Metabolism—FASN—ovarian cancer	1.02e-05	0.00135	CbGpPWpGaD
Furosemide—CA7—Metabolism—TYMS—ovarian cancer	1.01e-05	0.00135	CbGpPWpGaD
Furosemide—CA5B—Metabolism—TYMS—ovarian cancer	1.01e-05	0.00135	CbGpPWpGaD
Furosemide—PGD—Disease—CAV1—ovarian cancer	1.01e-05	0.00134	CbGpPWpGaD
Furosemide—CA9—Metabolism—YAP1—ovarian cancer	1.01e-05	0.00134	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1e-05	0.00133	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC5A5—ovarian cancer	1e-05	0.00133	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1e-05	0.00133	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	9.95e-06	0.00132	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—MAPK1—ovarian cancer	9.93e-06	0.00132	CbGpPWpGaD
Furosemide—CA2—Metabolism—FASN—ovarian cancer	9.75e-06	0.00129	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	9.69e-06	0.00129	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC2A1—ovarian cancer	9.66e-06	0.00128	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC5A5—ovarian cancer	9.59e-06	0.00127	CbGpPWpGaD
Furosemide—CA12—Metabolism—ABCB1—ovarian cancer	9.56e-06	0.00127	CbGpPWpGaD
Furosemide—PGD—Disease—IL6ST—ovarian cancer	9.56e-06	0.00127	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.46e-06	0.00126	CbGpPWpGaD
Furosemide—CA12—Metabolism—TYMS—ovarian cancer	9.39e-06	0.00125	CbGpPWpGaD
Furosemide—CA1—Metabolism—FASN—ovarian cancer	9.35e-06	0.00124	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP1B1—ovarian cancer	9.26e-06	0.00123	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC2A1—ovarian cancer	9.26e-06	0.00123	CbGpPWpGaD
Furosemide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	9.2e-06	0.00122	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC5A5—ovarian cancer	9.19e-06	0.00122	CbGpPWpGaD
Furosemide—PGD—Disease—APC—ovarian cancer	9.18e-06	0.00122	CbGpPWpGaD
Furosemide—CA14—Metabolism—CAV1—ovarian cancer	8.98e-06	0.00119	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VEGFA—ovarian cancer	8.94e-06	0.00119	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP1B1—ovarian cancer	8.88e-06	0.00118	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC2A1—ovarian cancer	8.88e-06	0.00118	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	8.86e-06	0.00118	CbGpPWpGaD
Furosemide—CA6—Metabolism—CAV1—ovarian cancer	8.75e-06	0.00116	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CAV1—ovarian cancer	8.75e-06	0.00116	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	8.51e-06	0.00113	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP1B1—ovarian cancer	8.51e-06	0.00113	CbGpPWpGaD
Furosemide—PGD—Metabolism—CAV1—ovarian cancer	8.44e-06	0.00112	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—ovarian cancer	8.33e-06	0.00111	CbGpPWpGaD
Furosemide—ALB—Metabolism—NME2—ovarian cancer	8.32e-06	0.0011	CbGpPWpGaD
Furosemide—CA9—Metabolism—FASN—ovarian cancer	8.22e-06	0.00109	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPP2R1A—ovarian cancer	8.21e-06	0.00109	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CG—ovarian cancer	8.18e-06	0.00109	CbGpPWpGaD
Furosemide—CA7—Metabolism—CAV1—ovarian cancer	8.17e-06	0.00108	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CAV1—ovarian cancer	8.17e-06	0.00108	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC5A5—ovarian cancer	8.08e-06	0.00107	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CD—ovarian cancer	8.07e-06	0.00107	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.07e-06	0.00107	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CG—ovarian cancer	7.97e-06	0.00106	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CG—ovarian cancer	7.97e-06	0.00106	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.89e-06	0.00105	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—ovarian cancer	7.88e-06	0.00105	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPP2R1A—ovarian cancer	7.87e-06	0.00105	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC2A1—ovarian cancer	7.81e-06	0.00104	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CG—ovarian cancer	7.69e-06	0.00102	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.65e-06	0.00101	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IL6—ovarian cancer	7.63e-06	0.00101	CbGpPWpGaD
Furosemide—CA4—Metabolism—ABCB1—ovarian cancer	7.63e-06	0.00101	CbGpPWpGaD
Furosemide—CA12—Metabolism—CAV1—ovarian cancer	7.57e-06	0.001	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPP2R1A—ovarian cancer	7.55e-06	0.001	CbGpPWpGaD
Furosemide—CA4—Metabolism—TYMS—ovarian cancer	7.49e-06	0.000994	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP1B1—ovarian cancer	7.48e-06	0.000993	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CG—ovarian cancer	7.44e-06	0.000988	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CG—ovarian cancer	7.44e-06	0.000988	CbGpPWpGaD
Furosemide—CA2—Metabolism—ABCB1—ovarian cancer	7.31e-06	0.000971	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL6—ovarian cancer	7.21e-06	0.000957	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CD—ovarian cancer	7.19e-06	0.000954	CbGpPWpGaD
Furosemide—CA2—Metabolism—TYMS—ovarian cancer	7.18e-06	0.000953	CbGpPWpGaD
Furosemide—PGD—Disease—ERBB2—ovarian cancer	7.13e-06	0.000946	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SPARC—ovarian cancer	7.06e-06	0.000937	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	7.06e-06	0.000937	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CB—ovarian cancer	7.04e-06	0.000934	CbGpPWpGaD
Furosemide—PGD—Disease—MTOR—ovarian cancer	7.04e-06	0.000934	CbGpPWpGaD
Furosemide—CA1—Metabolism—ABCB1—ovarian cancer	7.01e-06	0.00093	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CD—ovarian cancer	7.01e-06	0.00093	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CD—ovarian cancer	7.01e-06	0.00093	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CG—ovarian cancer	6.89e-06	0.000915	CbGpPWpGaD
Furosemide—CA1—Metabolism—TYMS—ovarian cancer	6.88e-06	0.000914	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CD—ovarian cancer	6.76e-06	0.000897	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPP2R1A—ovarian cancer	6.64e-06	0.000881	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	6.63e-06	0.00088	CbGpPWpGaD
Furosemide—PGD—Disease—CDKN1B—ovarian cancer	6.6e-06	0.000876	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CD—ovarian cancer	6.54e-06	0.000868	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CD—ovarian cancer	6.54e-06	0.000868	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CB—ovarian cancer	6.27e-06	0.000832	CbGpPWpGaD
Furosemide—PGD—Disease—CTNNB1—ovarian cancer	6.24e-06	0.000828	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCB1—ovarian cancer	6.16e-06	0.000818	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CB—ovarian cancer	6.11e-06	0.000811	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CB—ovarian cancer	6.11e-06	0.000811	CbGpPWpGaD
Furosemide—PGD—Disease—PTEN—ovarian cancer	6.08e-06	0.000807	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CD—ovarian cancer	6.06e-06	0.000804	CbGpPWpGaD
Furosemide—CA9—Metabolism—TYMS—ovarian cancer	6.05e-06	0.000803	CbGpPWpGaD
Furosemide—CA4—Metabolism—CAV1—ovarian cancer	6.04e-06	0.000801	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CB—ovarian cancer	5.89e-06	0.000782	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	5.83e-06	0.000773	CbGpPWpGaD
Furosemide—CA2—Metabolism—CAV1—ovarian cancer	5.79e-06	0.000768	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.75e-06	0.000764	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	5.73e-06	0.00076	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CB—ovarian cancer	5.7e-06	0.000757	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CB—ovarian cancer	5.7e-06	0.000757	CbGpPWpGaD
Furosemide—CA1—Metabolism—CAV1—ovarian cancer	5.55e-06	0.000736	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CG—ovarian cancer	5.5e-06	0.00073	CbGpPWpGaD
Furosemide—PGD—Disease—STAT3—ovarian cancer	5.44e-06	0.000722	CbGpPWpGaD
Furosemide—PGD—Disease—NRAS—ovarian cancer	5.42e-06	0.00072	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTEN—ovarian cancer	5.42e-06	0.000719	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.38e-06	0.000714	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYTB—ovarian cancer	5.36e-06	0.000712	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CB—ovarian cancer	5.28e-06	0.000701	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTEN—ovarian cancer	5.28e-06	0.000701	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTEN—ovarian cancer	5.28e-06	0.000701	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CG—ovarian cancer	5.27e-06	0.0007	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.24e-06	0.000696	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.2e-06	0.00069	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK3—ovarian cancer	5.2e-06	0.00069	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SOD1—ovarian cancer	5.13e-06	0.000681	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PPP2R1A—ovarian cancer	5.11e-06	0.000678	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTEN—ovarian cancer	5.09e-06	0.000676	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	5.08e-06	0.000674	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CG—ovarian cancer	5.05e-06	0.000671	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—ovarian cancer	5.05e-06	0.000671	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK1—ovarian cancer	4.94e-06	0.000656	CbGpPWpGaD
Furosemide—PGD—Disease—EGFR—ovarian cancer	4.94e-06	0.000656	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTEN—ovarian cancer	4.93e-06	0.000654	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTEN—ovarian cancer	4.93e-06	0.000654	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAV1—ovarian cancer	4.88e-06	0.000647	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CD—ovarian cancer	4.83e-06	0.000641	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPP1CC—ovarian cancer	4.69e-06	0.000622	CbGpPWpGaD
Furosemide—ALB—Metabolism—BRIP1—ovarian cancer	4.69e-06	0.000622	CbGpPWpGaD
Furosemide—PGD—Disease—KRAS—ovarian cancer	4.67e-06	0.00062	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	4.66e-06	0.000619	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CD—ovarian cancer	4.63e-06	0.000615	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTEN—ovarian cancer	4.56e-06	0.000606	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CG—ovarian cancer	4.44e-06	0.00059	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CD—ovarian cancer	4.44e-06	0.00059	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CA—ovarian cancer	4.29e-06	0.000569	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CB—ovarian cancer	4.21e-06	0.000559	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.1e-06	0.000545	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CB—ovarian cancer	4.04e-06	0.000536	CbGpPWpGaD
Furosemide—PGD—Disease—HRAS—ovarian cancer	3.97e-06	0.000527	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	3.96e-06	0.000526	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CD—ovarian cancer	3.91e-06	0.000518	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CB—ovarian cancer	3.87e-06	0.000514	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CA—ovarian cancer	3.82e-06	0.000507	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—ovarian cancer	3.8e-06	0.000504	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CAV1—ovarian cancer	3.75e-06	0.000498	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	3.75e-06	0.000498	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CA—ovarian cancer	3.72e-06	0.000494	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CA—ovarian cancer	3.72e-06	0.000494	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTEN—ovarian cancer	3.64e-06	0.000483	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CA—ovarian cancer	3.59e-06	0.000477	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	3.57e-06	0.000474	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—ovarian cancer	3.5e-06	0.000465	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTEN—ovarian cancer	3.49e-06	0.000463	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CA—ovarian cancer	3.48e-06	0.000461	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CA—ovarian cancer	3.48e-06	0.000461	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CG—ovarian cancer	3.42e-06	0.000454	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.42e-06	0.000453	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CB—ovarian cancer	3.4e-06	0.000452	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTEN—ovarian cancer	3.35e-06	0.000444	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CA—ovarian cancer	3.22e-06	0.000427	CbGpPWpGaD
Furosemide—ALB—Metabolism—YAP1—ovarian cancer	3.14e-06	0.000417	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—ovarian cancer	3.12e-06	0.000414	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.11e-06	0.000413	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	3.1e-06	0.000411	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—ovarian cancer	3.04e-06	0.000404	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—ovarian cancer	3.04e-06	0.000404	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CD—ovarian cancer	3e-06	0.000399	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTEN—ovarian cancer	2.94e-06	0.00039	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—ovarian cancer	2.93e-06	0.00039	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—ovarian cancer	2.84e-06	0.000377	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—ovarian cancer	2.84e-06	0.000377	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.73e-06	0.000363	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—ovarian cancer	2.63e-06	0.000349	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CB—ovarian cancer	2.62e-06	0.000348	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CA—ovarian cancer	2.57e-06	0.000341	CbGpPWpGaD
Furosemide—ALB—Metabolism—FASN—ovarian cancer	2.56e-06	0.00034	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	2.53e-06	0.000336	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC5A5—ovarian cancer	2.52e-06	0.000335	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CA—ovarian cancer	2.46e-06	0.000327	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A1—ovarian cancer	2.43e-06	0.000323	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IL2—ovarian cancer	2.4e-06	0.000319	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.38e-06	0.000316	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CA—ovarian cancer	2.36e-06	0.000313	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP1B1—ovarian cancer	2.33e-06	0.00031	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—ovarian cancer	2.1e-06	0.000278	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CA—ovarian cancer	2.08e-06	0.000275	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPP2R1A—ovarian cancer	2.07e-06	0.000275	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.06e-06	0.000273	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—ovarian cancer	2.04e-06	0.000271	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NRAS—ovarian cancer	2.02e-06	0.000268	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—ovarian cancer	2.01e-06	0.000267	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK3—ovarian cancer	1.93e-06	0.000257	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—ovarian cancer	1.93e-06	0.000256	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCB1—ovarian cancer	1.92e-06	0.000255	CbGpPWpGaD
Furosemide—ALB—Metabolism—TYMS—ovarian cancer	1.89e-06	0.000251	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK1—ovarian cancer	1.84e-06	0.000244	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KRAS—ovarian cancer	1.74e-06	0.000231	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—ovarian cancer	1.7e-06	0.000225	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CA—ovarian cancer	1.6e-06	0.000212	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—ovarian cancer	1.54e-06	0.000205	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAV1—ovarian cancer	1.52e-06	0.000202	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HRAS—ovarian cancer	1.48e-06	0.000196	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.45e-06	0.000193	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CG—ovarian cancer	1.39e-06	0.000184	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—ovarian cancer	1.3e-06	0.000173	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CD—ovarian cancer	1.22e-06	0.000162	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CB—ovarian cancer	1.06e-06	0.000141	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTEN—ovarian cancer	9.17e-07	0.000122	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CA—ovarian cancer	6.47e-07	8.59e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—ovarian cancer	5.29e-07	7.02e-05	CbGpPWpGaD
